Clinical Trials: Now Is the Time for Europe to Act - Benefit for 35,000 Patients and the Economy
2 Articles
2 Articles
If Europe regains its attractiveness in research and innovation, it will be able to help 35,000 European citizens access cutting-edge treatments, boost health systems…More...
35,000 Europeans will benefit from access to innovative medical treatment if the EU targets are met to attract clinical trials. This is assured by the European Federation of Pharmaceutical Associations and Industries (Efpia), which has published a study that states that EU health systems and the economy in general would also benefit from an additional €4 billion of funding per year, the creation of 18,000 new jobs and the prevention of three mil…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium

